TITLE

NEW PRODUCTS

PUB. DATE
August 2014
SOURCE
Monthly Prescribing Reference;Aug2014, Vol. 30 Issue 8, pA10
SOURCE TYPE
Periodical
DOC. TYPE
Product Review
ABSTRACT
The article offers brief information on two drugs including the Entyvio from the firm Takeda Pharmaceuticals and the Zontivity from the firm Merck & Co.
ACCESSION #
97429689

 

Related Articles

  • REPORTERS Notebook.  // Drug Store News;2/27/2012, Vol. 34 Issue 3, p42 

    The article offers information related to drug approval by the U.S. Food and Drug Administration (FDA) including the approval of Janumet XR from Merck & Co. Inc., Gleevec from Novartis AG, and the availability of Edarbyclor from Takeda Pharmaceutical Co. Ltd.

  • GASTROINTESTINAL TRACT.  // Monthly Prescribing Reference;Jun2011, Vol. 27 Issue 6, p167 

    The article offers information on the drugs used for treating gastrointestinal tract diseases. Amoxil from GlaxoSmithKline can be helpful in treating duodenal ulcer disease. Dexilant from Takeda Pharmaceutical Co. Ltd. is helpful in treating erosive esophagitis and heartburn and Pepcid from...

  • PHARMA CAPSULES.  // Pharmaceutical Technology;Dec2014, Vol. 38 Issue 12, p56 

    The article offers pharmaceutical industry news briefs as of December 2014. Roche has announced to invest on a diagnostic manufacturing facility in Suzhou, China. Merck of Germany and Pfizer have collaborated to develop MSB0010718C, an investigational anti-PD-LI antibody, to treat various types...

  • New Name, Same Drug.  // Pharmaceutical Representative;Apr2010, Vol. 40 Issue 4, p8 

    The article reports on the change of name of the proton pump inhibitor dexlansoprazole by the U.S. subsidiary of Takeda from Kapidex to Dexilant after incidents of confusion with the drugs Casodex, a prostate cancer treatment, from AstraZeneca, and Kadian, chronic pain treatment, from Actavis.

  • Kazano.  // Monthly Prescribing Reference;Aug2013, Vol. 29 Issue 8, pA13 

    The article offers brief information on the Kazano drug from Takeda Pharmaceutical Co. Ltd.

  • Nesina.  // Monthly Prescribing Reference;Aug2013, Vol. 29 Issue 8, pA14 

    The article offers brief information on the Nesina drug from Takeda Pharmaceutical Co. Ltd.

  • Oseni.  // Monthly Prescribing Reference;Aug2013, Vol. 29 Issue 8, pA16 

    The article offers brief information on the Oseni drug from Takeda Pharmaceutical Co. Ltd.

  • NOW AVAILABLE.  // Drug Topics;1/8/2007, Vol. 151 Issue 1, p59 

    The article evaluates the Duetact, a drug for the treatment of type 2 diabetes, developed by Takeda Pharmaceuticals Co. Ltd.

  • NOT ALL GLITAZONES ARE THE SAME!  // Pulse;1/23/2008, Vol. 68 Issue 2, p22 

    The article presents an advertisement for the prescription drug pioglitazone which is marketed under the name Actos by Takeda Pharmaceutical Co. Ltd.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics